SAB Biotherapeutics Inc share price logo

SAB Biotherapeutics Inc Share Price

NASDAQ: SABS

Small Cap

$3.64

+0.12

(+3.41%)

Live

as on

SAB Biotherapeutics Inc Stock Performance

as on April 28, 2026 at 2:11 am IST

  • Day's Low

    $3.52
    $3.64
    downward going graph

    3.30%

    Downside

  • 52 Week's Low

    52 Week's High

    $1.53
    $6.60
    downward going graph

    57.97%

    Downside

    81.32%

    Upside

    downward going graph

SAB Biotherapeutics Inc share price movements today

Previous Close
$3.52
Open
$3.52
Volume
507.8K
Day's Low - High
$3.52 - $3.64
52 Week Low - High
$1.53 - $6.60

SAB Biotherapeutics Inc Historical Returns

1 Month Return
-8.57 %
3 Month Return
-17.76 %
1 Year Return
+ 101.14 %
3 Year Return
-60.89 %
5 Year Return
0 %

SAB Biotherapeutics Inc Stock Fundamentals & Key Indicators

Check SAB Biotherapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$247.4M

EPS (TTM)

-0.3

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.60%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-45.9M

Revenue (TTM)

114.7K

Profit Margin

0.00%

Return On Equity TTM

14.96%

SAB Biotherapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of SAB Biotherapeutics Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
SAB Biotherapeutics Inc image
SAB Biotherapeutics Inc
BUY$247.4MNANA0.00%
Alnylam Pharmaceuticals Inc image
Alnylam Pharmaceuticals Inc
BUY$40.8B116.23%131.78.45%
Vertex Pharmaceuticals Inc image
Vertex Pharmaceuticals Inc
BUY$109.5B99.64%28.132.94%
BeiGene, Ltd. image
BeiGene, Ltd.
NA$33.4BNA121.785.37%
Regeneron Pharmaceuticals Inc image
Regeneron Pharmaceuticals Inc
BUY$79.5B52.82%18.1131.41%

Stock Returns calculator for SAB Biotherapeutics Inc Stock including INR - Dollar returns

The SAB Biotherapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

SAB Biotherapeutics Inc investment value today

Current value as on today

₹2,30,049

Returns

₹1,30,049

(+130.05%)

Returns from SAB Biotherapeutics Inc Stock

₹1,08,000 (+108%)

Dollar Impact

₹22,049 (+22.05%)

Analyst Recommendation on SAB Biotherapeutics Inc Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for SAB Biotherapeutics Inc. Average target price of $9.5

SAB Biotherapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on SAB Biotherapeutics Inc.

What analysts predicted

61.68%UPSIDE

Target Price

$9.5

Current Price

$3.64

Analyzed by

8 Analysts

Target

$9.50

SAB Biotherapeutics Inc target price $9.5, a slight upside of 61.68% compared to current price of $3.64. According to 8 analysts rating.

SAB Biotherapeutics Inc Stock’s Investor Sentiment and Interest

Search interest for SAB Biotherapeutics Inc Stock has decreased by -28% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-28% versus previous 30 day period

SAB Biotherapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
1
0
0
0
0
0
-
-
-
-
Gross Profit
0
0
-1
0
0
0
0
0
0
0
Operating Income
-5
-18
-11
-10
-11
-10
-10
-9
-12
-15
EBITDA
-4
-21
-2
-6
-9
-10
-4
-9
46
-16
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
1
1
0
0
0
0
0
0
Income Before Tax
-5
-22
-5
-7
-10
-11
-5
-10
45
-16
Income Tax Expense
0
0
-13
-
-
13
-
-
-
-
Net Income
-5
-22
-5
-7
-10
-11
-5
-10
45
-16
Net Profit Margin
-402.68%
-7493.83%
-532.06%
-2787.69%
2524246.34%
-9934.52%
0.00%
0.00%
0.00%
0.00%

SAB Biotherapeutics Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
3
55
60
23
2
1
-
Gross Profit
3
55
59
20
-1
-3
-3
Operating Income
-8
20
-13
-28
-38
-42
-48
EBITDA
-8
21
-15
-15
-38
-28
16
Interest Expense
0
0
0
0
0
0
0
Depreciation
0
0
1
1
3
4
3
Income Before Tax
-8
20
-17
-18
-42
-34
13
Income Tax Expense
0
0
0
0
0
-
-
Net Income
-8
20
-17
-18
-42
-34
13
Net Profit Margin
-261.07%
36.42%
-28.16%
-78.40%
-1884.50%
-2579.03%
0.00%

SAB Biotherapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-22
-5
-7
-10
-11
-5
-10
5
-16
Operating Cash Flow
-13
-10
-7
-6
-9
-7
-7
-13
-16
Investing Cash Flow
0
-31
11
-1
9
4
5
-129
-1
Financing Cash Flow
67
0
0
0
0
0
0
168
0
Change in Cash
54
-42
3
-8
0
-3
-1
25
-18

SAB Biotherapeutics Inc Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
20
-17
-18
-42
-34
13
Operating Cash Flow
10
1
-23
-25
-34
-44
Investing Cash Flow
-12
-10
-2
0
-11
-121
Financing Cash Flow
8
35
1
66
-1
168
Change in Cash
6
26
-24
41
-47
1

Global Institutional Holdings in SAB Biotherapeutics Inc

Funds
Holdings
Tower Research Capital LLC
0.01%
Marshall Wace Asset Management Ltd
0.34%
The Goldman Sachs Group Inc
0.07%
Mccormack Advisors International
0%
RA Capital Management, LLC
6.26%
See all

Insights on SAB Biotherapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, SABS has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, -410.0 → 114.69K (in $), with an average increase of 100.4% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, SAB Biotherapeutics Inc has experienced a drawdown of -60.9%, however Alnylam Pharmaceuticals, Inc. resisted the overall trend and outperformed by 55.8%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, SABS stock has moved down by -8.6%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 45.44M → -16.86M (in $), with an average decrease of 137.1% per quarter

About SAB Biotherapeutics Inc

SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of human polyclonal immunotherapeutic antibodies to address immune system disorders and infectious diseases in the United States. Its lead product candidate is SAB-142, a potentially disease-modifying and redosable immunotherapy in clinical development for the treatment of autoimmune type 1 diabetes in Phase 2b clinical trials. The company was founded in 2014 and is headquartered in Miami Beach, Florida.
OrganisationSAB Biotherapeutics Inc
Headquarters777 W 41st St., Miami Beach, FL, United States, 33140
IndustryBiotechnology
CEOMr. Samuel J. Reich
E-voting on sharesClick here to vote

Key Management of SAB Biotherapeutics Inc

Name

Title

Mr. Samuel J. Reich

CEO & Director

Dr. Eddie Joe Sullivan Ph.D.

Co-Founder, President & Director

Dr. Christoph Bausch M.B.A., Ph.D.

Executive VP & COO

Ms. Cristi Barnett

Vice President of Investor Relations & Corporate Communications

Ms. Catherine DeRose

Vice President of Human Resources

Ms. Lucy To

Executive VP & CFO

Dr. Alexandra Kropotova M.B.A., M.D.

Executive VP & Chief Medical Officer

Ms. Hua Wu Ph.D.

Senior Vice President of Product Development

Dr. Carlos N. Carillo M.Sc., Ph.D.

Senior Vice President of Regulatory Affairs

Ms. Angie Parizek

Senior Vice President of Clinical Operations

FAQs

What is SAB Biotherapeutics Inc share price today?

SAB Biotherapeutics Inc share price today is $3.64 as on . SAB Biotherapeutics Inc share today touched a day high of $3.64 and a low of $3.52.

What is the 52 week high and 52 week low for SAB Biotherapeutics Inc share?

SAB Biotherapeutics Inc share touched a 52 week high of $6.6 on and a 52 week low of $1.53 on . SAB Biotherapeutics Inc stock price today i.e. is trending at $3.64,which is 44.85% down from its 52 week high and 137.91% up from its 52 week low.

What is SAB Biotherapeutics Inc's market capitalisation today?

SAB Biotherapeutics Inc market capitalisation is $0.00T as on .

How to invest in SAB Biotherapeutics Inc Stock (SABS) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for SAB Biotherapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in SAB Biotherapeutics Inc Shares that will get you 0.4121 shares as per SAB Biotherapeutics Inc share price of $3.64 per share as on April 27, 2026 at 8:41 pm IST.

What is the minimum amount required to buy SAB Biotherapeutics Inc Stock (SABS) from India?

Indian investors can start investing in SAB Biotherapeutics Inc (SABS) shares with as little as ₹94.19 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹941.90 in SAB Biotherapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on SAB Biotherapeutics Inc share’s latest price of $3.64 as on April 27, 2026 at 8:41 pm IST, you will get 2.7473 shares of SAB Biotherapeutics Inc. Learn more about fractional shares .